Mauro Santambrogio’s 2013 season began like a career transformation. Riding for Vini Fantini–Selle Italia, the Italian climber finished sixth overall at the Tour de San Luis, seventh at Tirreno–Adriatico, won the rain-soaked GP Industria & Artigianato di Larciano after Patrik Sinkewitz crashed with two kilometers remaining, and placed second overall at the Giro del Trentino. At the Giro d’Italia, he attacked alongside race leader Vincenzo Nibali on Stage 14 and won the mountain finish, briefly moving to fourth overall and to within one second of Rigoberto Urán’s podium position. His sudden elevation from respected professional to Grand Tour contender immediately prompted doping rumors within the peloton, particularly as his form later collapsed and he fell to ninth overall.
On June 3, 2013, Santambrogio was announced to have tested positive for erythropoietin, or EPO, from a sample taken after the first stage of the Giro. The case came only weeks after his teammate Danilo Di Luca had been expelled from the same race following his own positive EPO test, deepening the scandal around the Vini Fantini team. Santambrogio was dismissed by the team and suspended by the UCI until November 2, 2014. His history had already drawn scrutiny: he had been mentioned in Italy’s Mantova doping investigation in 2010 and was temporarily sidelined by BMC, then sidelined again in 2011 when additional evidence emerged. Before even reaching the end of that suspension, he tested positive for testosterone on October 22, 2014, receiving a further three-year ban. Santambrogio said he would not attempt a comeback after serving it, bringing an abrupt end to a career whose most spectacular performances became inseparable from repeated doping violations.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.